Increasing evidence indicate that both N-glycosylation and O-glycosylation are implicated in AD, emphasized by the fact that the two hallmark proteins APP and Tau carry both potential N-glycosylation and O-glycosylation sites. Here, MAPT is linked to Alzheimer disease.